Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 April 2023 | Story Gerda-Marié van Rooyen | Photo Charl Devenish
Jenna Clarkson
Jenna Clarkson is a devout communications student and a karateka. She had to deal with several health challenges during her studies, but nevertheless dreams of obtaining her PhD in Communication at the UFS.

Overcoming numerous health obstacles during her studies, Jenna Clarkson is in high spirits after obtaining her degree from the University of the Free State (UFS). While most students enjoyed an active social and campus life, she often had to visit the hospital while studying. Receiving her BA Integrated Organisational Communication qualification during the April 2023 graduation ceremony has been a healing balm after many years of pain. 
 
The Faculty of the Humanities graduate was diagnosed with type 2 diabetes in 2021. In 2022, after several physiotherapists and emergency room visits, she was also diagnosed with juvenile disc disorder and sacroiliitis. The latter condition affects one or both sacroiliac joints where the lower spine and pelvis meet and may cause pain in one or both legs. 

Initially, Jenna assumed she had hurt herself during karate practice, but the pain would not subside. “I would randomly lose feeling in my legs and couldn’t sit. I spent a year in pain and struggled to walk, lift heavy objects, cough, and sleep on my side. I struggled with the fact that this was going to be an issue for the rest of my life.” 

However, with a lot of love from her friends, support from her lecturers, and grace with herself, Jenna learned how to handle the pain and to realise when she has met her limits. This student from Johannesburg says that although pain is frustrating and overwhelming, having emotional support helps. “Sometimes just having someone to listen and be there is the best thing.”

The journey to the graduation stage might have been difficult for this high-flyer, but it was a worthwhile undertaking. 

“I feel over the moon, and a little overwhelmed that it happened,” says Jenna about getting her degree in communications. Loving her field of study, she attended class eagerly and enjoyed her modules. “I love that I am allowed to create, I get to make something. There’s nothing more amazing than getting a brief and being able to look at it and create something from it that nobody else would have created. The bonus is that I am quite good at it too,” adds the student who is currently doing her honours degree at the UFS. 

Getting her first degree from the UFS, Jenna is determined to excel in her chosen field. 

“I would like to get my honours degree cum laude and do a PhD degree, but I am taking it one degree at a time. If it doesn’t work out that way, it’s okay. I am very good at figuring things out and making a plan.”

Jenna is determined to make her parents proud. “Having lost my dad at four, I do everything with the hope that he would be proud of my choices. My mom sacrificed a lot to give me the best life she could.”

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept